Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients
2017
Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
43
References
46
Citations
NaN
KQI